Leica Microsystems has launched the SCN400 2.2 scanning platform which features batch processing in brightfield as well as multi-channel fluorescence, integrated with convenient workflows, and therefore serves to be a high efficiency solution for digital pathology scanning.
The SCN400 2.2 includes up to five fluorescence channels per slide, thereby delivering a versatile whole slide scanning solution. Having clear focus and channel separation, Leica’s SCN400 2.2 enables clear capturing of multiple markers on a single sample, through which researchers can obtain results from exceptional or rare samples. As this novel platform can hold multiple filter cubes, up to seven distinct fluorescence channels can be effectively used throughout a scanning batch, thereby promoting flexible scanning of various kinds of samples in pharmaceutical and research labs.
The SCN400 2.2 has been designed to achieve compliance with the requirements of brightfield as well as fluorescence imaging in a single scanning platform. Individual fluorophores with similar wavelengths can be precisely separated using monochrome detectors for fluorescence, while color detectors for brightfield ensure exceptional digital slide capture quality.
The advanced tissue finding system in brightfield imaging facilitates automatic detection of the areas for capture. Leica’s patented Dynamic Focus ensures rapid scanning of high resolution whole slide images, by eliminating the slide pre-mapping’s overhead. The SCN400 2.2 has been equipped with the SL801 autoloader that can accommodate 384 slides and therefore serves to be an automated high-throughput system.
Leica’s Total Digital Pathology ensures complete end-to-end solutions for scanning, analysis and optimization of digital pathology images. The SCN400 2.2 is a major part of Leica’s product line contributing to unequaled flexibility and performance. This novel platform will promote slide scanning to be an integrated, simple step in the pathology workflow.
Source: http://www.leica-microsystems.com/